In this article, we shall cover the top 10 oncology companies in the world. To skip our detailed analysis of the global oncology industry in 2023, go directly and see Top 30 Oncology Companies in the World.
10. Abbott Laboratories (NYSE:ABT)
Market Cap: $168.07B
Headquartered in Abbott Park, Illinoi, Abbott Laboratories (NYSE:ABT) is an American multinational medical devices and health care company. The company produces diagnostic products, medical devices, and treatments for various diseases, including cancer.
9. Pfizer Inc. (NYSE:PFE)
Market Cap: $187.3B
Based in The Spiral, New York City, Pfizer Inc. (NYSE:PFE) is an American multinational pharmaceutical company, which primarily focuses on areas like immunology, oncology, and cardiology. In oncology, the pharmaceutical company targets breast, prostate, gastric, and ovarian cancers. Through research and development, Pfizer Inc. (NYSE:PFE) is also exploring various therapeutic areas like cancer vaccines and precision medication.
8. AstraZeneca Plc. (NYSE:AZN)
Market Cap: $210.6B
Headquartered in Cambridge, England, AstraZeneca plc. (NYSE:AZN) is an Anglo-Swedish pharmaceutical and biotechnology company, which has a diverse range of products for diseases which fall under oncology, cardiovascular, gastrointestinal, etc. Some of their key products for treating cancer include Olaparib, Imfinzi, and Daliresp.
7. Novartis AG (NYSE:NVS)
Market Cap: $212.2B
Based in Basel, Switzerland, Novartis AG (NYSE:NVS) is a multinational pharmaceutical corporation. Two of its main business units include oncology and pharmaceutical. As part of its oncology segment, the company mainly focuses on breast cancer and leukemia. Novartis (NYSE:NVS) produces various cancer-treatment medications namely Afinitor, Femara, and Kisqali.
6. Roche Holding AG (OTC:RHHBY)
Market Cap: $220.8B
Based in Basel, Switzerland, Roche Holding AG (OTC:RHHBY) is a multinational healthcare company, which has a diverse portfolio of products for diseases including cancer, virus, and metabolic diseases. Roche Holding AG (OTC:RHHBY) is particularly popular for its drug development under oncology. Some of the cancer-treatment drugs include Alecensa, Herceptin, Kadcyla, and Perjeta.
5. Bayer AG (ETR:BAYN)
Market Cap: $240.01B
Headquartered in LeverKusen, Germany, Bayer AG (ETR:BAYN) is a multinational pharmaceutical and biotechnology company. It produces a range of products centered around cardiology, women’s healthcare, oncology, and ophthalmology. Bayer AG’s (ETR:BAYN) oncology product portfolio mainly counters gastrointestinal stromal tumors, liver cancer, prostate cancer, and kidney cancer.
4. Merck & Co., Inc. (NYSE:MRK)
Market Cap: $261.2B
Based in Rahway, New Jersey, Merck & Co., Inc. (NYSE:MRK) is a multinational pharmaceutical company founded in 1891. The company produces cancer immunotherapy, anti-diabetic medications, and vaccines against HPV and chickenpox. Keytruda, Lynparza, and Gardasil are names of some key cancer-treatment products created by Merck & Co., Inc. (NYSE:MRK).
3. AbbVie Inc. (NYSE:ABBV)
Market Cap: $263.1B
Headquartered in North Chicago, Illinois, AbbVie Inc. (NYSE:ABBV) is a pharmaceutical company. The company is committed to create and engage in product development for cancer, neurological diseases, and eye care. Ever since its creation in 2012, AbbVie Inc. (NYSE:ABBV) has produced medications for the treatment of different types of cancer. Some of these medications include Imbruvica, Venclexta, and Epcoritamab.
2. Johnson & Johnson (NYSE:JNJ)
Market Cap: $375.05B
Based in New Brunswick, New Jersey, Johnson & Johnson (NYSE:JNJ) is an American multinational pharmaceutical and medical technologies company. The company is actively working on producing pharmaceutical prescription drugs and medical devices. Under the area of oncology, Johnson & Johnson (NYSE:JNJ) mainly focuses on prostate cancer and hematologic malignancies.
1. Eli Lilly & Company (NYSE:LLY)
Market Cap: $509.9B
Headquartered in Indianapolis, Indiana, Eli Lilly & Company (NYSE:LLY) is an American pharmaceutical company, which operates in 18 countries. Eli Lilly & Company (NYSE:LLY) produces a diverse portfolio of products for the treatment of diseases including cancer, polio, and mental disorders. Some of its key cancer-treatment products include Gemzar and Evista.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also take a peek at 18 Easiest and Affordable Commuter Towns to NYC in 2023 and 15 Untapped Small Business Ideas In Africa in 2023.
